STOK
NASDAQ · Biotechnology
Stoke Therapeutics Inc
$26.60
+0.53 (+2.03%)
STOK News6 articles
Pentagon Backs Stoke Space with $150M Conditional Loan for Second Launchpad
The Pentagon announced a $150 million conditional loan to Stoke Space to build a second launchpad at Cape Canaveral, supporting the larger Nova Block 2 rocket.
OpenAI's Navier-Stokes Claim: A Milestone or a Mirage?
OpenAI's bold Navier-Stokes proof could transform its valuation, but mathematical and business hurdles remain. Investors watch for independent validation and product viability.
ASX 200 Falls for Sixth Day as Oil Rally Stokes RBA Rate Jitters
The ASX 200 fell for a sixth consecutive session, closing at 8,710.7, as surging oil prices heightened inflation fears ahead of key CPI data.
Silver Retreats as Rate Cut Hopes Dim and Middle East Tensions Stoke Inflation
Silver declined 0.9% as major banks pushed back Fed rate cut projections. Escalating Middle East tensions threaten higher oil prices, potentially keeping inflation elevated and central banks on hold.
Dow Gains as Fed Decision Nears; Oil Prices Stoke Inflation Concerns
The Dow Jones Industrial Average advanced on Tuesday as investors positioned for the Federal Reserve's policy announcement, looking past elevated oil prices linked to Middle East tensions. Brent crude traded above $101 a barrel.
Indian Equities Under Pressure as Oil Surge, Rupee Weakness Stoke Macro Fears
Indian benchmarks extended losses Thursday, pressured by oil prices exceeding $100 a barrel and a record-low rupee. Analysts warn of a widening current account deficit and slower GDP growth.